Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib.
Ignatius Ou SH, Azada M, Hsiang DJ, Herman JM, Kain TS, Siwak-Tapp C, Casey C, He J, Ali SM, Klempner SJ, Miller VA. Ignatius Ou SH, et al. Among authors: herman jm. J Thorac Oncol. 2014 Apr;9(4):549-53. doi: 10.1097/JTO.0000000000000094. J Thorac Oncol. 2014. PMID: 24736079 Free article.
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
Ou SH, Bazhenova L, Camidge DR, Solomon BJ, Herman J, Kain T, Bang YJ, Kwak EL, Shaw AT, Salgia R, Maki RG, Clark JW, Wilner KD, Iafrate AJ. Ou SH, et al. J Thorac Oncol. 2010 Dec;5(12):2044-6. doi: 10.1097/JTO.0b013e318200f9ff. J Thorac Oncol. 2010. PMID: 21102269 Free article. No abstract available.
The power of personas: Exploring an innovative model for understanding stakeholder perspectives in an oncology learning health network.
Cooper DJ, Karten J, Hoffe SE, King DA, Weiss M, DePeralta DK, Coveler AL, Hingorani SR, Shefter T, Meguid C, Roberts H, Hong TS, Narang A, Hacker-Prietz A, Fisher GA, Sandler J, Singer L, Korah B, Hoos W, Stricker CT, Herman JM. Cooper DJ, et al. Among authors: herman jm. Learn Health Syst. 2024 May 27;9(1):e10422. doi: 10.1002/lrh2.10422. eCollection 2025 Jan. Learn Health Syst. 2024. PMID: 39822915 Free PMC article.
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereotactic Body Radiation Therapy Followed by FOLFIRINOX in High-Risk Resected Pancreatic Ductal Adenocarcinoma.
Hill CS, Parkinson R, Jaffee EM, Sugar E, Zheng L, Onners B, Weiss MJ, Wolfgang CL, Cameron JL, Pawlik TM, Rosati L, Le DT, Hacker-Prietz A, Lutz ER, Schulick R, Narang AK, Laheru DA, Herman JM. Hill CS, et al. Among authors: herman jm. Int J Radiat Oncol Biol Phys. 2024 Nov 14:S0360-3016(24)03561-2. doi: 10.1016/j.ijrobp.2024.10.039. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39547453
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy.
Sanford NN, Narang AK, Aguilera TA, Bassetti MF, Chuong MD, Erickson BA, Goodman KA, Herman JM, Intven M, Kilcoyne A, Kim H, Paulson E, Reyngold M, Tsai S, Tchelebi LT, Tuli R, Versteijne E, Wei AC, Wo JY, Zhang Y, Hong TS, Hall WA. Sanford NN, et al. Among authors: herman jm. Int J Radiat Oncol Biol Phys. 2024 Nov 6:S0360-3016(24)03516-8. doi: 10.1016/j.ijrobp.2024.10.026. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39510320 Review.
362 results